A bit of theorising here:
One thing that Ross mentioned in the interview is that the trial should be completed towards the middle of the year. This is also mentioned in the clinicaltrials.gov site where it says estimated completion date 2018-06, and also the half year report which says it should be completed by end of 2018 (presumably financial year).
Given completion is the 100 days after treatment, based on that we’re looking at 2 more weeks until they announce that cohort b has been treated. (2 more weeks plus 100 days takes us right to the end of June)
A bit of theorising here: One thing that Ross mentioned in the...
Add to My Watchlist
What is My Watchlist?
